PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX |
PRICE T ROWE ASSOCIATES INC | 4,834,813 8.000% |
1,046,697![]() (+27.63%) |
Filing |
2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
PRICE T ROWE ASSOCIATES INC | 3,788,116 6.300% |
3,788,116![]() (New Position) |
Filing |